Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209224
Company: AUROBINDO PHARMA LTD

Products on ANDA 209224

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	AA	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 209224

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/24/2024	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 209224

LACOSAMIDE

SOLUTION;ORAL; 10MG/ML
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	No	AA	214672	ALKEM LABS LTD
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	No	AA	204839	AMNEAL PHARMS
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	No	AA	206355	APOTEX
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	No	AA	209224	AUROBINDO PHARMA LTD
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	No	AA	209301	HETERO LABS LTD III
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	No	AA	216461	LEADING PHARMA
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	No	AA	215379	MSN
LACOSAMIDE	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	No	AA	216151	NOVITIUM PHARMA
VIMPAT	LACOSAMIDE	10MG/ML	SOLUTION;ORAL	Prescription	Yes	AA	022255	UCB INC